# Squamous Eccrine Ductal Carcinoma: A Comprehensive Review of the Clinicopathologic Features and Management in 27 Cases

**Authors:** Santiago Gudino-Rosales, Cullen M Lilley, Gregory Gates, Diana Kneiber

PMC · DOI: 10.7759/cureus.87037 · Cureus · 2025-06-30

## TL;DR

This study reviews 27 cases of a rare skin cancer called squamous eccrine ductal carcinoma, highlighting its features, challenges in diagnosis, and risks of recurrence and metastasis.

## Contribution

The paper provides a comprehensive clinicopathologic analysis of 27 SEDC cases, emphasizing its diagnostic challenges and clinical behavior.

## Key findings

- SEDC commonly occurs on sun-exposed areas, especially the head and neck, in older individuals.
- Despite surgical treatment, SEDC has a recurrence rate of 18.5%, with one case resulting in metastasis and death.
- SEDC's mixed histopathologic and immunophenotypic features make it difficult to distinguish from squamous cell carcinoma.

## Abstract

Squamoid eccrine ductal carcinoma (SEDC) is a rare cutaneous malignancy that demonstrates both squamous and eccrine differentiation. With a limited number of published cases in the literature, SEDC remains a diagnostic challenge. This retrospective chart review reports on 27 cases of SEDC identified at our institution and summarizes their clinical and histopathologic characteristics. Clinically, these tumors demonstrated a predilection for sun-exposed areas, favoring the head and neck (59.2%, n=16) of older individuals (median age 74 years). They presented as a papule, nodule, or plaque (48.1%, n=13) and were less than 2 cm in size. Despite surgical treatment with either conventional wide local excision or Mohs micrographic surgery, they had a local recurrence rate of 18.5% (n=5). One patient had metastatic disease with local recurrence, regional lymph node involvement, and distant skin metastasis, which led to the patient’s death. Given that SEDC histologically exhibits both squamous and eccrine differentiation and immunophenotypically expresses markers of both eccrine/adnexal and squamous origin, this carcinoma poses a diagnostic challenge, as superficial biopsies may be indistinguishable from squamous cell carcinoma. This study emphasizes the importance of recognizing this tumor due to its recurrence risk and potential for metastasis and mortality.

## Linked entities

- **Diseases:** squamous cell carcinoma (MONDO:0005096), metastatic disease (MONDO:0024883)

## Full-text entities

- **Genes:** MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}, CEACAM3 (CEA cell adhesion molecule 3) [NCBI Gene 1084] {aka CD66D, CEA, CGM1, CGM1a, W264, W282}
- **Diseases:** Necrosis (MESH:D009336), metastasis (MESH:D009362), basal cell carcinoma (MESH:D002280), papules (MESH:D000169), sweat duct and adnexal malignancies (MESH:D000292), death (MESH:D003643), pain (MESH:D010146), melanoma (MESH:D008545), microcystic adnexal carcinoma (MESH:C000632664), pruritus (MESH:D011537), forehead lesion (MESH:D006259), breast ductal carcinoma (MESH:D018270), inflammation (MESH:D007249), cancer (MESH:D009369), rectal adenocarcinoma (MESH:D000230), cutaneous carcinoma (MESH:C562393), eccrine carcinoma (MESH:D057090), MMS (MESH:D000267), myelodysplastic syndrome (MESH:D009190), cutaneous lesions (MESH:D009059), mucoepidermoid carcinoma (MESH:D018277), chronic lymphocytic leukemia (MESH:D015451), Mobile mass (MESH:D014086), SEDC (MESH:D044584), acantholysis (MESH:D000051), irritation (MESH:D001523), cervical cancer (MESH:D002583), unspecified thyroid cancer (MESH:D013964), shoulder lesion (MESH:D020069), ulcer (MESH:D014456), Bowen's/squamous cell carcinoma in situ disease (MESH:D002294), solar elastosis (MESH:D000092130), prostate carcinoma (MESH:D011472), breast adenocarcinoma (MESH:D001943), actinic keratosis (MESH:D055623), non-skin cancers (MESH:D012878), erythema (MESH:D004890), bleeding (MESH:D006470)
- **Chemicals:** ipilimumab (MESH:D000074324), cisplatin (MESH:D002945), paclitaxel (MESH:D017239), H&amp;E (MESH:D006371), nivolumab (MESH:D000077594), carboplatin (MESH:D016190), cetuximab (MESH:D000068818), cemiplimab (MESH:C000627974)
- **Species:** Nicotiana tabacum (American tobacco, species) [taxon 4097], Human immunodeficiency virus 1 (no rank) [taxon 11676], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12309865/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12309865/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC12309865/full.md

---
Source: https://tomesphere.com/paper/PMC12309865